Pump, pipes, and filter: do SGLT2 inhibitors cover it all?
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference11 articles.
1. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies;Lancet Diabetes Endocrinol,2018
2. Mortality and cardiovascular disease in type 1 and type 2 diabetes;Rawshani;N Engl J Med,2017
3. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored;McMurray;Lancet Diabetes Endocrinol,2014
4. SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review;Verma;Diabetologia,2018
5. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synergistically improved cardiovascular outcomes in type 2 diabetes mellitus patients with combined treatment of SGLT-2 inhibitors and pioglitazone;Frontiers in Endocrinology;2024-08-30
2. Sodium-Glucose Cotransporter-2 Inhibitors and Nephritis Among Patients With Systemic Lupus Erythematosus;JAMA Network Open;2024-06-12
3. Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium–Glucose Cotransporter 2 Inhibitors;Advances in Therapy;2023-11-09
4. Diastolische Dysfunktion und HFpEF bei CKD;Die Nephrologie;2023-09-18
5. Exploring the comparative cardiovascular death benefits of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network meta-analysis-based scoring;Frontiers in Endocrinology;2023-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3